Prodrugs for Improved Oral β-Estradiol Bioavailability
- 1 January 1988
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 05 (1) , 44-47
- https://doi.org/10.1023/a:1015863412137
Abstract
Prodrugs of β-estradiol (1) were prepared with the objective of improving its oral bioavailability. β-Estradiol-3-acetylsalicylate (2), β-estradiol-3-salicylate (3), and β-estradiol-3-anthranilate (4)...This publication has 9 references indexed in Scilit:
- Prodrugs for improved oral nalbuphine bioavailability: inter-species differences in the disposition of nalbuphine and its acetylsalicylate and anthranilate estersInternational Journal of Pharmaceutics, 1987
- Improvement of the Oral Bioavailability of Naltrexone in Dogs: A Prodrug ApproachJournal of Pharmaceutical Sciences, 1987
- Biological Effects of Estradiol-17β in Postmenopausal Women: Oral Versus percutaneous AdministrationJournal of Clinical Endocrinology & Metabolism, 1986
- The metabolism of estradiol; oral compared to intravenous administrationThe Journal of Steroid Biochemistry and Molecular Biology, 1985
- Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: Comparison with conventional oral estrogens used for hormone replacementAmerican Journal of Obstetrics and Gynecology, 1985
- New Lipophilic Terbutaline Ester Prodrugs with Long Effect DurationPharmaceutical Research, 1984
- Comparison of pharmacodynamic properties of various estrogen formulationsAmerican Journal of Obstetrics and Gynecology, 1982
- Comparison of the metabolism in dogs of estradiol-17β following its intravenous and oral administrationThe Journal of Steroid Biochemistry and Molecular Biology, 1980
- Oral long-lasting estrogenic activity of estradiol 3-benzoate 17-cyclooctenyl etherSteroids, 1972